We have a brand new MOA to prove that generic is just a steroid . It’s apples and oranges we have a unique molecule .
Thanks Hugh, gotta give you this- you do stick to the teleprompter. What effin idiot! When you use fruit to do comparisons, stick to Melons- moron!
One the new MoA. It’s so interesting. My docs are saying “now you tell me. I’m going to write the shti out of this product now. This is an amazing story. Can’t wait to tell my fellow docs about it. Wow!!! Really mind blowing stuff. Really. Now please pass me another chicken sandwich”.
NM “Generic ACTH will actually have to do real clinical trials and that takes time and money.” Besides, we all know from HP Acthar gel that it never meets endpoint. Generic ACTH is not a threat.
only to get an indication. Off label use all day long. But keep thinking that Nate. Acthar is dying a slow death. Soon to speed up
IS HE REALLY THAT STUPID? Generics DO NOT HAVE TO DO ANY TRIAL AT ALL. This is really elementary, think of all the generic meds you and ur family take. Now do u think that all those had to do trials? NO! What a freaking DA.
yeah, unfortunately I fear you’rethe idiot. There are no generics for biologics...only biosimilars who must prove effectiveness. Go back to your simplistic pharma world and pass out your co-pay cards and stick to your routing
previous poster is correct, several generic biologics on market that had to do no trials, depends on generic equivalent rating. What you are saying used to be absolute but many exceptions now.
A - synacthin not a generic B - not proven equivalency C - need to understand orphan drug/biologics which it doesn’t appear you do D - You’re wrong on biosimilars - there are several in market BECAUSE they’ve proven equivalency on effectiveness....like remicade etc and a few others you need to educate yourself. And stay current before spouting. That being said payers would push anything they feel is cheaper and they can get away with even if it’s worse. Unfortunately they have not yet nor have they tried to prove equivalency...probably because they know they can’t or it would be too expensive.
because Acthar has??? Lmao. What a joke. They don’t have to prove shti. Will be used off la el and the insurance company will push it. End of story. If Acthar applied for an NDA today it wouldn’t have a chance in hell to get pproved
hysterical. Numerous circular arguments pointing out your knowledge of unimportant nonsense . Pdufa 2 weeks. If approved it will be an option away from acthar. But the biosimilars have clinical not trails with yes no equivalence but no the generics too. -that’s what your back and forth sounds like.
